Sartorius and HOF Sonderanlagenbau, have partnered to integrate two HOF horizontal plate freeze-thaw units into Sartorius’ portfolio, offering customers a full suite of compatible freeze-thaw equipment and consumables. This partnership will enable faster and easier implementation of robust frozen drug substance management platforms through improved validation and purchase support from a single supplier.

“With this partnership, Sartorius continues to strengthen its leading position in the freeze-thaw market,” said Eva Lindskog, Head of Fluid Management Technologies at Sartorius. “The combination of our robust Celsius single-use containers with market-leading freeze-thaw equipment from HOF will provide our customers with a simplified supply chain for improved management of drug substance.”

A key criterion in the drug substance freeze-thaw process is the ability to reliably control cooling and heating to prevent cryo-concentration. The combination of the new Celsius consumables, with HOF’s adjustable plate system, provides predictability, robustness, and reproducibility.

The partnership builds on Sartorius’ 15-year success in developing proven freeze-thaw solutions for customers worldwide and reinforces the company’s commitment to global access to cold chain product and process innovation.